Other studies link elevated IFN levels in the blood with the severity of COVID-19 patients’ symptoms [265], as well as the ineffectiveness of IFN in antiviral protection of airway epithelial cells and its potential to induce ACE2 expression on intestinal epithelial cells [266]. The gene discussed is IFNA1; the disease is COVID-19.